Back

Effect of traditional Chinese medicine Qiliqiangxin in patients With HFrEF treated with sacubitril/valsartan: the QUEST trial

31 August 2026 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: HFrEF therapy: beyond current standards Heart Failure with Reduced Ejection Fraction (HFrEF) ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Iok Fai Cheang

The First Affiliated Hospital of Nanjing Medical University, Nanjing (China)

6 More presentations in this session

Presentation thumbnail
Integrating six-minute walk distance into a simple multimarker score improves risk stratification in advanced HFrEF
Doctor M. Chudy (Bratislava, SK)
Abstract
Presentation thumbnail
Multicentre validation of an AI model for detection of reduced left ventricular ejection fraction
Mr R. Rama (Groningen, NL)
Abstract
Presentation thumbnail
NT-proBNP and UACR for outcome prediction in HFrEF
Doctor N. Panagiotides (Vienna, AT)
Abstract
Presentation thumbnail
Effects of sacubitril/valsartan versus enalapril on NT-proBNP and hs-troponin T in patients with heart failure due to Chagas disease: insights from the PARACHUTE-HF trial
Doctor L. Echeverria (Floridablanca, CO)
Abstract
Presentation thumbnail
Validation of an AI‑ECG tool to detect left ventricular systolic dysfunction in community-based patients with suspected heart failure and elevated NT‑proBNP.
Doctor U. Razzaq (Glasgow, GB)
Abstract

Access the full session

Session thumbnail
HFrEF therapy: beyond current standards

The Event

Event poster

ESC Congress 2026

31 August 2026 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Discussant review - QUEST
26 August 2023
thumbnail
Congress Presentation
Efficacy and safety of sacubitril/valsartan in patients with acute decompensated heart failure: a systematic review and meta-analysis
2 December 2022
thumbnail
Congress Presentation
Benefit of ivabradine on clinical status and quality of life in Chinese population with chronic heart failure: results from POSITIVE study
29 June 2021
thumbnail
Congress Presentation
The implementation of modern guideline-directed medical therapy among hospitalized patients with heart failure with reduced ejection fraction: real-world experience from two tertiary cardiac centers
30 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources